OMED
OncoMed Pharmaceuticals, Inc.
NasdaqGS
People also watch:EPZMXLRNMGNXPTLAAGIO
12.18-0.08 (-0.65%)

After hours: 12.180.00 (0.00%) as of 4:44 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close12.26
Open12.32
Bid11.28 x 200
Ask0.00 x
52wk Range8.42 - 23.98
Day's Range12.06 - 12.34
Volume67,916
Avg Vol (3m)182,446
As of 4:00 PM EDT. Market closed.
  • OncoMed Pharmaceuticals, Inc. – Value Analysis (NASDAQ:OMED) : July 5, 2016
    Capital Cube20 days ago

    OncoMed Pharmaceuticals, Inc. – Value Analysis (NASDAQ:OMED) : July 5, 2016

    Click here to see latest analysisCapitalcube gives OncoMed Pharmaceuticals, Inc. a score of 29.Our analysis is based on comparing OncoMed Pharmaceuticals, Inc. with the following peers – Celgene Corporation, Regeneron Pharmaceuticals, Inc., Acceleron Pharma Inc, Endocyte, Inc., GlaxoSmithKline plc Sponsored ADR, Stemline Therapeutics, Inc., Verastem, Inc., ImmunoCellular Therapeutics, Ltd. and Cerulean Pharma, Inc. (CELG-US, REGN-US, […] (Read more...) The post OncoMed Pharmaceuticals, Inc. – Value Analysis (NASDAQ:OMED) : July 5, 2016 appeared first on CapitalCube.

  • OncoMed Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : OMED-US : July 4, 2016
    Capital Cube21 days ago

    OncoMed Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : OMED-US : July 4, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for OncoMed Pharmaceuticals, Inc.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBullishClosing Price above/below 200 Day Moving AverageBearish50 Day Moving Average above/below 200 Day Moving […] (Read more...) The post OncoMed Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : OMED-US : July 4, 2016 appeared first on CapitalCube.